Analytical performance and method comparison study of the total homcysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 2, 2004, Pages 228-234

  Lonati, Silvia ^a   Novembrino, Cristina ^b   Ippolito, Silvia ^a   Accinni, Roberto ^c   Galli, Claudio ^d   Troonen, Hugo ^e   Campolo, Jonica ^c   Della Noce, Cinzia ^c   Lunghi, Giovanna ^b   Bamonti Catena, Fabrizia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d ABBOTT DIAGNOSTICS   (Italy)

^e ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Fluorescence polarization immunoassay (FPIA); High performance liquid chromatography (HPLC); Homocysteine; Method comparison

Indexed keywords

HOMOCYSTEINE;

ACCURACY; AMINO ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE ANALYSIS; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; VASCULAR DISEASE;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENCE POLARIZATION IMMUNOASSAY; HOMOCYSTEINE; HUMANS;

EID: 12144285688     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.041     Document Type: Article

References (38)

1. Mangoni AA, Jackson SHD. Homocysteine and cardiovascular disease: Current evidence and future prospects. Am J Med 2002;112:556-65.
2. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998;49:31-62.
3. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
4. Stampfer MJ, Malinow MR, Willett WC. Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992;268:877-81.
5. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82.
6. Refsum H. Total homocysteine. Guidelines for determination in the clinical laboratory. Clin Lab News 2002;2:12-4.
7. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 1993;39:263-71.
8. Pfeiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 1999;45:290-2.
9. Schroder G, editor. Evaluation of the Abbott IMx homocysteine assay. Wiesbaden: Abbott Diagnostic Division, 1998:1-87.
10. Zighetti ML, Chantarangkul V, Tripodi A, Mannucci PM, Cattaneo M. Determination of total homocysteine in plasma: Comparison of the Abbott IMx immunoassay with high performance liquid chromatography. Haematologica 2002;87:89-94.
11. Blanco-Vaca F, Arcelus R, González-Sastre F, Ordóñez-Llanos, Queraltó-Compañó JM. Comparison of the Abbott IMx and a high-performance liquid chromatography method for measuring total plasma homocysteine. Clin Chem Lab Med 2000;38:327-9.
12. Pfeiffer CM, Twite D, Shih J, Holets-McCormack SR, Gunter EW. Method comparison for total plasma homocysteine between the Abbott IMx analyzer and an HPLC assay. Clin Chem 1999;45:152-3.
13. Pernet P, Lasnier E, Vaubourdolle M. Evaluation of the AxSYM homocysteine assay and comparison with the IMx homocysteine assay. Clin Chem 2000;46:1440-1.
14. Bamonti-Catena F, Accinni R, Novembrino C, Campolo J, Naggi P, Buccianti G, et al. Analytical and clinical performance evaluation of the IMx homocysteine assay compared to EIA and HPLC. In: Schroder G, editor. Evaluation of the Abbott IMx homocysteine assay. Wiesbaden: Abbott Diagnostic Division, 1998:63-6.
15. Cavalca V, Cighetti G, Bamonti-Catena F, Loaldi A, Bortone L, Novembrino C, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001; 47:887-92.
16. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx Analyzer. Clin Chem 1995;41:991-4.
17. Accinni R, Campolo J, Bartesaghi S, De Leo G, Lucarelli C, Cursano CF, et al. High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards. J Chromatogr 1998;828:397-400.
18. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1997;277:1775-81.
19. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;274:1049-57.
20. 6 on clinical outcome after percutaneous coronary intervention. J Am Med Assoc 2002;288:973-9.
21. Brunelli T, Pepe G, Marcucci R, Giusti B, Prisco D, Abbate R, et al. Comparison of three methods for total homocysteine plasma determination. Clin Lab 2001;47:393-7.
22. Barbé F, Abdelmouttaleb I, Chango A, Gérard P, Quilliot D, Klein M, et al. Detection of moderate hyperhomocysteinemia: Comparison of the Abbott fluorescence polarization immunoassay with the Bio-Rad and SBD-F high-performance liquid chromatographic assays. Amino Acids 2001;20:435-40.
23. Leino A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx analyzer. Clin Chem 1999;45:569-71.
24. Mansoor MA. Comparison of Abbott IMx total homocysteine assay with a high pressure liquid chromatography method for the measurement of total homocysteine in plasma and serum from a Norwegian population. Scand J Clin Lab Invest 1999;59:369-74.
25. Tripodi A, Chantarangkul V, Lombardi R, Lecchi A, Mannucci PM, Cattaneo M. Multicenter study of homocysteine measurement - performance characteristics of different methods, influence of standards on interlaboratory agreement of results. Thromb Haemost 2001;85:291-5.
26. Wu AHB, Holtman V, Apple FR, Ricchiuti V, DiBello PM, Jacobsen D. Multicenter analytical evaluation of an automated immunoassay for total plasma homocysteine. Ann Clin Lab Sci 2000;30:185-90.
27. Pfeiffer CM, Huff DL, Smith JS, Miller DT, Gunter EW. Comparison of plasma total homocysteine measurements in 14 laboratories: an international study. Clin Chem 1999;45:1261-8.
28. Nexo E, Engbaek F, Ueland PM, Wesrby C, O'Gorman P, Johnston C, et al. Evaluation of novel assays in clinical chemistry: quantification of plasma total homocysteine. Clin Chem 2000;46:1150-6.
29. Møller J, Rasmussen K, Christensen L. External quality assessment of methylmalonic acid and total homocysteine. Clin Chem 1999;45:1536-42.
30. Sigit JI, Hages M, Brensing KA, Frotscher U, Pietrzik K, von Bergmanmn K, et al. Total plasma homocysteine and related amino acids in end-stage renal disease (ESRD) patients measured by gas chromatography-mass spectrometry - comparison with the Abbott IMx homocysteine assay and the HPLC method. Clin Chem Lab Med 2001;39:681-90.
31. Magera MJ, Lacey JM, Casetta B, Rinaldo P. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 1999;45:1517-22.
32. Ubbink JB, Delport R, Riezler R, Vermaak WJH. Comparison of three different plasma homocysteine assays with gas chromatography-mass spectrometry. Clin Chem 1999;45:670-5.
33. Donnelly JG, Pronovost C. Evaluation of the Abbott IMx™ fluorescence polarization immunoassay and the Bio-Rad enzyme immunoassay for homocysteine: Comparison with high-performance liquid chromatography. Ann Clin Biochem 2000;37:194-8.
34. Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8-12.
35. Rasmussen K, Møller J. Methodologies of testing. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge: Cambridge University Press, 2001:199-211.
36. Kuo K, Still R, Cale S, McDowell I. Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 1997;43:1653-5.
37. Dierkes J, Luley C, Troonen H, Michel G. Comparison of AxSYM, HPLC and IMx total homocysteine assays in patients with normal and elevated homocysteine. AACC 2002. Proceedings of the 54th American Association of Clinical Chemistry Annual Meeting; 2002 Jul 28-Aug 1; Orlando, Florida, USA. Abstract C-81.
38. Rosenberg IH. Is it time to standardize and to measure blood homocysteine levels in patients with heart disease Am J Med 2002;112:582-3.